XECAN, a leading innovator in advanced oncology solutions assisted by artificial intelligence, is excited to announce its participation in the upcoming ASTRO 66th Annual Meeting 2024 to showcase its research and innovations to those attending. XECAN will showcase its state of the art AI-assisted products designed to elevate precision, efficiency and improve the overall patient workflow experience.

All visitors are cordially invited to visit our booth and take a look at our presentations. Join our colleagues and staff and learn more about our AI-assisted Clinic Solutions, Radiation Oncology, Chemotherapy, Patient Facial Recognition, Patient accessory verification, and more.

Booth No: 3029

Meeting Dates: September 29 - October 2, 2024

In-Person Location: Walter E. Washington Convention Center, Washington, D.C

Previously, we exhibited our software products at ASTRO’s 2018,2019,2022 and 2023 Annual Meetings.

Our experts will provide immersive demonstrations of our innovative products, seamlessly integrating AI algorithms to optimize patient positioning, facial recognition, and workflow management during radiation treatment. XECAN invites all participants to engage with these cutting-edge technologies and explore how they are reshaping the future of radiation oncology.

For more information about XECAN's participation in ASTRO 2024 and to schedule appointments with their team.

Please get in touch with us:

Email: info@xecan.com

Toll-Free: 1866-469-3226

Int'l: 617-588-0098

Fax: 508-276-0006

About XECAN: XECAN provides AI-assisted clinic solutions to improve clinic workflow, patient tracking, treatment safety and overall quality of patient care. XECAN is a pioneering company developing innovative AI-assisted oncology solutions that empower healthcare providers to deliver precise and personalized radiation therapy. By seamlessly integrating artificial intelligence into its products, XECAN aims to enhance patient outcomes and treatment efficiency, setting new standards in radiation oncology care. Through continuous research and collaboration, XECAN remains dedicated to advancing the field and ensuring patients receive the most effective and compassionate treatment possible.

#xecan #xecanatastro #booth3029  #astro2024

On 16 April 2024, XECAN, a leading innovator in advanced oncology solutions assisted by artificial intelligence, presents an AI Lung Cancer Prediction tool. The goal of this tool is to enhance early detection and intervention, as early diagnosis often improves treatment outcomes. By identifying individuals at a higher risk of developing lung cancer, healthcare providers can tailor screening programs and preventive measures to potentially reduce the impact of the disease.

What sets it apart is its ability to detect potential risks at an earlier stage compared to human doctors, thereby significantly mitigating the need for unnecessary biopsies. This not only ensures a more streamlined and cost-effective diagnostic process but also alleviates patient anxiety and discomfort associated with unnecessary medical procedures.

The XECAN Lung Screen tool stands out as a groundbreaking solution, leveraging the advanced capabilities of the Sybil lung screen AI model. This innovative technology provides a swift and comprehensive risk prediction for lung cancer, spanning a significant 1-6 year timeframe, all achieved through the simplicity of a single CT scan.

Sybil was collaboratively developed by MIT's Abdul Latif Jameel Clinic for Machine Learning in Health, the Mass General Cancer Center (MGCC), and Chang Gung Memorial Hospital (CGMH). Sybil has undergone validation using three independent datasets: a set of 6,282 LDCTs from NLST participants, 8,821 LDCTs from Massachusetts General Hospital (MGH), and 12,280 LDCTs from Chang Gung Memorial Hospital (CGMH), including individuals with diverse smoking histories, including nonsmokers. The Sybil model aims to predict short and long-term lung cancer risk based on a single LDCT upload, without the need for additional clinical data or radiologist annotations. Deep Learning Based Predictor of Future Lung Cancer Risk Sybil is currently not FDA-approved and is intended for utilization in testing and research endeavors.

XECAN intends to retrain Sybil with more LDCT images. If you're interested in utilizing the XECAN Lung Screen tool and helping to improve the model. please let us know.

The AI model can be accessed online by sending email to info@xecan.com

About XECAN: XECAN provides AI-assisted clinic solutions to improve clinic workflow, patient tracking, treatment safety, and overall quality of patient care. With a focus on innovation and personalized care, XECAN's mission is to enhance the healthcare experience for both patients and healthcare providers.

XECAN, a leading innovator in advanced oncology solutions assisted by artificial intelligence, is excited to announce its participation in the upcoming ASTRO 2023 65th annual meeting, the premier event for professionals in the field of radiation oncology. XECAN will showcase its state of the art AI-assisted products designed to elevate precision, efficiency and improve the overall patient workflow experience.

Booth # 3422 

Meeting and Exhibition Dates: October 1 - 4, 2023

Location: San Diego Convention Center, San Diego

XECAN's team of experts will provide immersive demonstrations of their innovative AI-assisted products, which seamlessly integrate AI algorithms to optimize patient positioning, facial recognition and workflow management during radiation treatment. XECAN invites all participants to engage with these cutting-edge AI-assisted technologies and explore how they are reshaping the future of radiation oncology.

For more information about XECAN's participation in ASTRO 2023 and to schedule appointments with their team.

Please contact us :

Email: info@xecan.com

Toll-Free: 1866-469-3226

Int'l: 617-588-0098

Fax: 508-276-0006

About XECAN: XECAN provides AI-assisted clinic solutions to improve clinic workflow, patient tracking, treatment safety and overall quality of patient care. XECAN is a pioneering company developing innovative AI-assisted oncology solutions that empower healthcare providers to deliver precise and personalized radiation therapy. By seamlessly integrating artificial intelligence into their products, XECAN aims to enhance patient outcomes and treatment efficiency, setting new standards in radiation oncology care. Through continuous research and collaboration, XECAN remains dedicated to advancing the field and ensuring patients receive the most effective and compassionate treatment possible.

#xecanatastro #booth3422 #astro2023

Boston, MA On August 15, 2023,  XECAN, a leading innovator in healthcare technology, is thrilled to announce the launch of its  AI-assisted clinic solution that improves clinic workflow, patient tracking, treatment safety and overall quality of patient care. This cutting-edge solution harnesses facial recognition and advanced clinic algorithms to elevate patient care to unprecedented levels. Designed to cater to a wide range of multidisciplinary clinics and departments, including Radiation, Chemotherapy, Exam Rooms, Labs, Medical Oncology, PET, and Surgical Rooms, this system promises to revolutionize the healthcare experience.

With a strong focus on personalized care, XECAN's solution equips each specific treatment unit with its own unique workflow management whiteboards tailored to its specific needs. For example, within the surgical room, the facial recognition technology seamlessly registers patients in various areas such as surgical waiting, on-hold, in-suit, recovery, and discharge, all through the convenience of surgical whiteboards. This streamlined approach ensures a smoother and more efficient patient journey throughout their treatment process.

The AI-assisted workflow solution takes healthcare to new heights by offering a seamless and touchless approach, eliminating the need for manual handling by clinic staff. Through the power of facial recognition technology, the system effortlessly tracks patients throughout their entire journey, from reception to exam rooms, infusion areas, surgical suites, PET scans, labs, and treatment rooms.

By employing sophisticated algorithms and precise facial recognition, the solution ensures that each patient is directed to the appropriate waiting room, informing them about their waiting status. In cases where multiple appointments are required, the system efficiently communicates this information to patients through interactive whiteboards, streamlining their visit and ensuring a smooth transition from one appointment to the next.

Once inside the clinic units, the AI system again identifies the patient, guaranteeing that the right patient receives the correct medicine and treatment. This level of accuracy significantly enhances patient safety and the effectiveness of care.

The system not only optimizes workflow efficiency but also sets new standards for safety and patient care quality in clinics. By eliminating manual processes and leveraging cutting-edge AI capabilities, this solution is transforming the future of healthcare delivery.

As of XECAN product release 6.6, the following departments are actively supported:

1. Radiation Oncology

2. Medical Oncology

3. Infusion Room (Chemotherapy)

4. Exam-rooms

5. Labs

6. Breast Imaging

7. PET

8. Surgical 

9. Radiology

For more details please check out different relative sections above.

For a web demo contact us at sales@xecan.com or visit our website at www.xecan.com

About XECAN:

XECAN provides AI-assisted clinic solution to improve clinic workflow, patient tracking, treatment safety and overall quality of patient care. With a focus on innovation and personalized care, XECAN's mission is to enhance the healthcare experience for both patients and healthcare providers.

Boston, MA On Jan 16, 2023, the Eskilstuna Malarsjukhuset radiation clinic went live with their XECAN integration, including XECAN smart clinic and CRAD cAutoVerify. The combined deployments enable the clinic to improve clinic workflow, along with patient safety and experience from reception and treatment rooms.

XECAN facial recognition automatically checks patients in as soon as they enter the clinic. Patients receive a personalized greeting at the kiosk and their arrival integrates into on-site MOSAIQ software. The patient then moves to the waiting room, which contains a XECAN’s patient ID whiteboard. The board’s live updates provide patients with their expected wait and treatment time, therefore alleviating potential stress. Once patients relocate to the treatment area, the software removes patients’ IDs from the board, all without manual staff intervention.

The treatment rooms contain CRAD cAutoVerify in front of the radiation vault. The facial recognition in the dome camera minimizes medical errors by ensuring that the right patients enter the right locations. Their personal treatment chart is verified simultaneously.

“The hospital staff's favorite part of the XECAN health system is the facial recognition. It is very useful and user-friendly. The system significantly improves our workflow and patient safety. The XECAN staff was also immensely helpful throughout” commented Goran Dahl, Lead Technician, Eskilstuna Malarsjukhuset, Sweden

“Eskilstuna clinic is a very innovative clinic. Its staff are devoted to improve patient care. It was an honor to work with them. We also like to thank our technology partner CRAD. It works very closely with us in the successfully implementation” according to Bin Yang. CEO of XECAN

For more information on XECAN solution: info@xecan.com

About Eskilstuna Malarsjukhuset:

Mälarsjukhuset in Eskilstuna is Sörmland's largest hospital. The site is responsible for the care and treatment of primary residents within the northern part of the county (Eskilstuna and Strängnäs municipalities) with nearly 140,000 inhabitants. At Mälarsjukhuset, medical, surgical and psychiatric healthcare is provided, both acute and planned. The hospital has joint clinics with the Kullbergska hospital in Katrineholm and provides specialist expertise that is used for patients throughout Sörmland and in some cases also in Västmanland.

About XECAN:

XECAN was founded in 2010 and uses proprietary software to transform cancer clinics into smart clinics. XECAN is the leading provider of smart clinics and touchless technology. The system improves clinic workflow and patient treatment safety, as well as the overall quality of patient care. The XECAN suite has five modular sub-systems: patient auto-queuing, exam room workflow & tracking, electronic whiteboards, and patient auto-verification.

Boston, MA On July 1st, 2022, XECAN developed Mask-On Facial Recognition for Berkshire Medical Center’s Radiation Oncology. The system improves workflow while enhancing patient care efficiency and quality.  The deployment includes the following modules:

• Reception Area: Smart Patient Check-in KIOSK

• Waiting Area: Patient Waiting and Calling Whiteboard

• Exam Rooms: Clinic/Exam Room Workflow

• Treatment room: Treatment Time Out Process

• Treatment room: Patient Accessory Verification (PAVS)/RFID Accessory Verification

• SIM Room: Patient Enrollment and RFID tagging

• More: Hardware Shipment, Installation, Staff Training, Certification

• Clinic/Exam Rooms workflow portal: Real-time Patient and Staff workflow and clinic room utilization tracking

• Berkshire special: Patient chart opening feature 

Thanks to partnerships with Elekta and Varian, XECAN fully integrates with both Aria and MOSAIQ, the two most utilized EMR systems. Powered by the latest neuron network and template matching algorithm, XECAN’s face ID identifies patients consistently and reliably. The software focuses on patients’ uncovered areas, such as the eyes and forehead, meaning the system can identify patients even when they wear masks. Compared to a dome camera patient verification system, the masked patients achieve the same level of accuracy with about one second of a delay.

Facial recognition technology provides a first-class experience to both patients and staff. Most importantly, XECAN’s software optimizes safety by ensuring that every patient receives their documented treatment in their delegated location. XECAN is among the first software companies internationally to achieve this upgrade. The team at XECAN is proud to provide Berkshire Medical Center—and radiation centers worldwide—with their sleek, touchless experience.

“XECAN is user-friendly and easy to use. It is highly innovative and provides a unique solution to patient verification and workflow.” comments by Shaun Weigand, Project Manager, Berkshire Health System, United States

“The fact patients can be recognized with masks on makes the solution extremely patient friendly. We are very pleased to observe how effective it is in clinic setups” according to Bin Yang CEO of XECAN

For more information on XECAN solution: info@xecan.com

About Berkshire Health System:

Berkshire Health Systems is the leading provider of comprehensive healthcare services for residents and visitors to Berkshire County. From inpatient surgery and cancer care to provider visits and imaging, Berkshire Health Systems (BHS) offers a continuum of programs and services that help patients to connect to the care they need, no matter where they are located in the rural Berkshire community.

About XECAN:

XECAN was founded in 2010 and uses proprietary software to transform cancer clinics into smart clinics. XECAN is the leading provider of smart clinics, and touchless technology and its solution improve clinic workflow and patient treatment safety, as well as the overall quality of patient care. The XECAN suite has five modular sub-systems: patient auto-queuing, exam room workflow & tracking, electronic whiteboards, and patient auto-verification.

ASTRO is a great occasion for exhibitors to showcase their research and innovations to those attending the 64th Annual Meeting join your colleagues and staff to learn more about your concerns related to Radiation Oncology, Chemotherapy, Patient Facial Recognition, Patient accessory verification, and much more.

Booth No: 2721 

Meeting Dates: October 23 - 26, 2022

Exhibition Dates: October 23 - 25, 2022

Location: Henry B. Gonzalez Convention Center in San Antonio

With a recent product update, XECAN became the first software company worldwide to achieve mask-on facial recognition, with the first to utilize its first-class facial recognition technology and options for patient and staff safety, and improved hospital workflow. The software is in general public distribution to provide the XECAN touchless experience. Visitors will experience and present a complete demo in a real-time environment at the meeting.

Previously, we exhibited our software product at ASTRO’s 60th Annual Meeting 2018 and  61st Annual Meeting 2019

XECAN will show the following modules in real-time with patient workflow at the show:

• Smart Reception

• Patient Calling Board

• Smart Clinic Whiteboard

• Patient accessory verification

• XECAN’s Chemotherapy

XECAN’s Radiotherapy Suite

• Fully integrated with MOSAIQ & ARIA

• Reception Area:  Smart Patient Reception Kiosk

• Waiting Area:  Patient Directory Whiteboard

• Staff Area:  Clinic Workflow Whiteboards

• Treatment Room: Smart Patient Identification

• Treatment Room: Smart Treatment Accessory Verification

• Clinical Analytics Reporting Engine

Note:  The following functions are modules that can be deployed independently.

XECAN’s Chemotherapy

• Fully integrated with MOSAIQ/ARIA/EPIC

• Reception Area: Smart Patient Reception Kiosk

• Waiting Area: Patient Directory Whiteboard

• Staff Area: Clinic Workflow Whiteboards

• Chemotherapy Administration Safety Verification

• Clinical Analytics Reporting Engine

You can contact us for more details and queries:

Email: info@xecan.com

Toll-Free: 1866-469-3226

Int'l: 617-588-0098

Fax: 508-276-0006

Boston, MA On July 1st 2022, XECAN develops Mask-On Facial Recognition for Radiation Oncology for Berkshire Medical Center. Which aims to improve workflow, and increase patient care efficiency and quality.

Powered by the latest neuron network and improved template matching algorithm, the XECAN face ID software can identify patients consistently and reliably with or without a mask on. It focuses on the uncovered areas, such as the eyes and forehead. Compared with patient verification with a dome camera, the masked patients achieve the same level of accuracy with about a 1-second delay.

XECAN is among the first software companies worldwide to achieve this upgrade, and the first to utilize its first-class facial recognition technology and options for patient and staff safety, and improved hospital workflow. The software is in general public distribution to provide XECAN touchless experience. 

When a patient enters the clinic, they are automatically recognized and checked into MOSAIQ, ARIA, EPIC, or other EMR systems. While he/she walks into the treatment or exam room, his/her treatment chat is automatically opened. This is accomplished, crucially, without requiring patients to take off their masks. 

In addition to the patient identification, treatment accessories are tracked with the latest RFID tags to make sure the right patient and the right accessories for every patient. This easy-to-use technology brings the clinic treatment accuracy to the next level.

The mask-on facial recognition solution was in clinic use at Berkshire Medical Center, MA, USA

Berkshire Health Systems is the leading provider of comprehensive healthcare services for residents and visitors to Berkshire County. From inpatient surgery and cancer care to provider visits and imaging, Berkshire Health Systems (BHS) offers a continuum of programs and services that help patients to connect to the care they need, no matter where they are located in the rural Berkshire community.       

XECAN looks forward to a long and fruitful relationship with Berkshire Health Systems as we continue to provide them with the Best Smart Clinic Solutions we can offer. As we support their mission to advance health and wellness for everyone in their community in a welcoming, inclusive, and personalized environment.

XECAN Smart Clinic successfully develops a national CT lung screening registry for research and reporting purposes for Rescue Lung Society(RLS) which aims to empower lung health and reduce health disparities through prevention and early detection.

A national CTLS registry will provide precedence in data and trends analytics to further drive the mission of RLS to save lives at risk for lung cancer through high-quality CTLS today and pioneering early detection innovations tomorrow.

At the beginning of 2020, RLS planned to build a national CTLS registry for research and reporting purposes. The site will allow users to enroll either through self-enrollment or RLS-assisted enrollment. The registered users can view their data and compare it with aggregate registry data. The submitted data will be stored in a relational database to generate various analytics. RLS administrators will have a hierarchical view of all submitted data, registered accounts, and users. The registry will be hosted in a HIPAA-compliant cloud and all the data submissions will be encrypted. The site’s architecture is a highly scalable cluster with fail-over servers with an available uptime of 99.999%. The cluster is deployed on the Amazon cloud.

Among different software vendors, XECAN was selected to design, develop and maintain the registry.

“We are very pleased to have the opportunity to work with the Rescue Lung Society to build the registry and get it done within budget and on time” commented XECAN CEO, Dr. Bin Yang

“It was truly a pleasure to be able to work with XECAN in developing this registry. Their experience in healthcare and HIPAA compliance allowed us to build a registry that we feel will allow sites to easily and effectively share and compare data to improve the overall quality of CTLS and increase screening rates.” comments from Dr. Shawn Regis, Secretary of the Rescue Lung Society.

The Rescue Lung Society (RLS) was founded by a multidisciplinary group of clinicians and research scientists with a decade-long track record of CTLS innovation including originating the currently accepted standard CTLS reporting system (Lung-RADS), pioneering community benefit CTLS, prototyping the first commercially available dedicated CTLS program management system, establishing the first state-sponsored CTLS learning collaborative, publishing the only commercially available CTLS reading simulator and training tool (MeVis Lung Academy), identifying novel lung cancer biomarkers, and successfully lobbying CMS to establish CTLS reimbursement. 

The registry is available online at https://registry.rescuelung.org

XECAN has been developing large-scale HIPAA compliant patient portals and has been running and supporting the department of radiation oncology centers for the last ten years. Please contact info@xecan.com for additional information. 

XECAN is pleased to announce that Version 6, Release 1 is now available for general distribution. V6.1 provides support with a dome IP camera for treatment verification of patients: walk-in, wheelchair and patients on stretchers. V6.1 also includes many other enhancements.

Automatically Identify Patients: walk-in, wheelchair, or patients on stretchers

Developed based on the XECAN advanced facial recognition algorithm to improve patient safety and clinic workflow, the dome camera combined with facial recognition further enhances these functions.  

Once the patient enters the treatment room, the XECAN smart solution automatically adjusts its camera tilt angle to identify the incoming patient Instantly. Further, the patient ID is used to verify ARIA or MOSAIQ patient treatment chat.

Physics World visited the XECAN booth at the 61’st ASTRO Annual Meeting. They conducted an on-site interview with XECAN CEO Bin Yang. Dr. Yang gave a brief overview of XECAN technology with in booth demonstrations. The interview video can be viewed by clicking on the image below:

XECAN at ASTRO’s 61st Annual Meeting 2019

• Sun. Sept 15, 2019 – Tues. Sept 17, 2019

• McCormick Place West

• Chicago, IL

• Booth # 4330 Booth map (https://events.jspargo.com/astro19/public/EventMap.aspx?shavailable=1&shExhlist=1&ID=75518&sortMenu=103000 )

All are cordially invited to visit XECAN’s booth to view presentations of its newly developed products and features, furthering its goal of ensuring patient safety and improving clinic workflow efficiency. Presentations, in both ARIA and MOSAIQ R&V system settings, will feature the use of facial recognition for Reception, Exam and Treatment stations.

Canadian superhospital CHUM in Montreal chooses XECAN’s Face ID Safety Solution to be part of its clinical treatment time out protocol for Radiation Oncology treatments at their brand new Cancer Center. CHUM's Radiation Oncology Department has 10 treatment rooms. The implementation is expected to be completed during the first quarter of 2020.

After years of evaluation of various technologies in the marketplace, CHUM has selected the XECAN smart MOSAIQ facial recognition technology.. XECAN’s Smart Face ID solution will be integrated with Mosaiq, the centers EMR to clear the MOSAIQ patient safety interlock. , The technology will ensure the highest level of patient safety available on the market today. XECAN’s unique technology also allows for increased workflow efficiencies and a more positive patient experience.

To ensure XECAN/Mosaiq compatibility, XECAN has entered into a Vendor Interoperability Program Agreement with Elekta. Under this agreement, XECAN has re-designed and re-developed its patient verification component based on the Elekta PatientVerify platform available in version 2.6 and higher. This allows XECAN to use the standardized Elekta foundation for patient safety verification, which is fully supported by Elekta standard releases.

C-RAD and the US based company XECAN signed a partnership agreement to develop new products to advance patient positioning and resource management within radiation therapy.

The development work will start immediately with a team from both companies and will be done in several phases. A first version of the product is expected to be presented in the second quarter 2019. The XECAN technology will be fully integrated in C-RAD’s c4D software platform. C-RAD and XECAN also signed a distribution agreement that grants C-RAD the sales rights of the product in major markets. C-RAD is targeting new customers but will also provide a seamless upgrade path for customers that are already equipped with C-RAD technology.

XECAN is DBA (doing business as) of myRFIDSpace, Inc. XECAN is a Boston based company incorporated in Delaware, USA.

“More and more radiation clinics are looking for a full patient safety management solution,” says Bin Yang, Ph.D, CEO of XECAN, "XECAN wanted to find just the right partner to work with to meet the needs of the market. We are very delighted to work with C-RAD; the combined strength of both companies will not only expand both of our product lines, but also improve the quality of our services.”

“We are excited to enter into the cooperation with XECAN. This new partner has very strong technology expertise, whereas C-RAD has a very attractive software platform with a high level of integration to automate clinical workflows and a global sales organization to commercialize the new products in major markets.” says Tim Thurn, CEO and President of C-RAD AB, “It is the first step to broaden our offering, and at the same time strengthen our value proposition in the area of highly accurate patient positioning.”

About XECAN:

XECAN is the leading provider of smart clinic solutions through patient tracking and verification. Its solution improves clinic workflow, patient and treatment safety, and overall quality of patient care. XECAN’s smart integration technology enables its software to be seamlessly integrated with all major hospital EMR systems. XECAN provides the following five major functional modules: Smart Reception, Smart Exam-room Whiteboards, Smart Treatment Procedure Verification, Treatment Planning Workflow Whiteboards and Clinical Analytics Reporting.

About C-RAD

C-RAD develops innovative solutions for use in advanced radiation therapy. The C-RAD group offers products and solutions for patient positioning, tumor localization and radiation treatment systems. All product development is conducted in three fully owned subsidiaries: C-RAD Positioning AB, C-RAD Imaging AB and C-RAD Innovation AB, all of which are located in Uppsala, Sweden. C-RAD has established three companies for direct sales: C-RAD Inc. in the US, C-RAD GmbH in Germany. Cyrpa International SPRL, a Franco-Belgian laser company, is a wholly owned subsidiary whose operations are integrated. C-RAD AB is listed on NASDAQ Stockholm. 
For more information on C-RAD, please visit http://www.c-rad.com

For further information: 
Tim Thurn, CEO C-RAD AB, Phone +46-18-666930, Email investors@c-rad.com

XECAN’s facial recognition based system has just been implemented at Hopital Riviera-Chablais in Vevey, Switzerland. The deployed system has demonstrated accurate and real time facial recognition for queuing patients in the clinic’s MOSAIQ system, as well as verifying patients with their accessories, and clearing patients from the treatment rooms. Based on its performance, the clinic is already planning to expand the system in their new center.

XECAN is very proud to deliver a system that not only meets, but exceeds the clinic’s expectations, and we are looking forward to bringing the same benefits to other clinics with similar needs.

• Sun. Oct 21, 2018 – Tues. Oct 23, 2018

• Henry B. Gonzalez Convention Center

• San Antonio, Texas

• Booth # 2367 map

All are cordially invited to visit XECAN’s booth to view enhanced interactive demonstrations of its newly developed products and features, furthering its goal of ensuring patient safety and improving clinic workflow efficiency. Demonstrations, in both ARIA and MOSAIQ R&V system settings, will include the use of Facial, Palm and RFID recognition technologies for Reception, Exam and Treatment stations.

Switzerland's Hospital Riviera-Chablais selects XECAN’s FaceID cutting-edge smart technology to Improve Patient Identification and workflow management. 

XECAN today announced its compatibility with Elekta’s MOSAIQ  Patient Verification and Patient Queuing Modules. XECAN integrates palm, facial recognition and RFID identification devices to MOSAIQ via its software, bringing improvements to delivery of care.

Using smart ID technology, XECAN improves clinical workflow and patient satisfaction through the use of automation technology, removing human factors from the delivery of services. In addition to patient queuing and patient verification functions, XECAN also enables RFID-based accessory verification, helping therapists quickly verify personalized treatment accessories, such as vacuum bags and bolus material, adding assurance that personalized radiation therapy is carried out accurately according to each patient’s treatment plan.

XECAN is a member of Elekta’s third party Vendor Interoperability Program (VIP) and, based on the vendor’s tests in accordance with the Vendor Interoperability Program, XECAN validated its system’s use with Elekta’s MOSAIQ® oncology information system.

After joining Elekta’s VIP as one of its first partners, XECAN has been working closely with the Elekta MOSAIQ team in the integration of patient verification and patient queuing with smart technology such as palm scanning, facial recognition and RFID. These leading-edge technologies extend core MOSAIQ functions bringing human factor improvements to patient care and staff workflows. Not only have these solutions been successfully integrated with on-site MOSAIQ deployment, they have also recently been successfully integrated with a cloud-based MOSAIQ implementation for both patient queuing and patient verification in treatment rooms. The cloud-based solution has been operational in clinical use since October 2017.

“Since MOSAIQ is one of most used EMR systems in radiation clinics. It is vital for any third-party solution to fully integrate with MOSAIQ to best improve clinic quality of care,” said Bin Yang, Ph.D., CEO of XECAN. “Through its VIP program, Elekta demonstrated its desire to build a support system for innovators bringing leading-edge technology to MOSAIQ clinics. XECAN is proud to be one of the first partners in the program, and the results are very positive for our mutual customers.”

XECAN is a full patient care and safety management system, which supports both Aria and Mosaiq R&V systems and all types of treatment machines. Based on RFID and biometric tracking capability, XECAN has the following three major function modules: Smart RFID Reception, Patient & Accessory Verification, plus Smart Exam Room & Patient Tracking Whiteboards.